| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2191844C Acylated enol derivatives as prodrugs of elastase inhibitors |
| 07/24/2001 | CA2026540C Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions |
| 07/24/2001 | CA2019369C Sulfur-containing fused pyrimidine derivatives, their production and use |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051619A2 Genetically modified fibroblast cell |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051491A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | WO2001051480A1 Agents correcting gene expression regulatory error |
| 07/19/2001 | WO2001051474A2 Polypharmacophoric agents |
| 07/19/2001 | WO2001051473A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 07/19/2001 | WO2001051470A1 Phenanthridine-n-oxides |
| 07/19/2001 | WO2001051467A1 Indole derivatives as mcp-1 receptor antagonists |
| 07/19/2001 | WO2001051466A1 Indole derivatives as mcp-1 receptor antagonists |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051057A2 Glycosides and orthoester glycosides of glucocorticoids and uses thereof |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000073296A3 3-heteroarylalkyl substituted gaba analogs |
| 07/19/2001 | WO2000071104A3 Use of bisphosphonic acids for treating angiogenesis |
| 07/19/2001 | WO2000064485A9 Specifically targeted catalytic antagonists and uses thereof |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010008901 Nitrile derivatives that inhibit cathepsin K |
| 07/19/2001 | US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/19/2001 | US20010008888 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 07/19/2001 | DE10001166A1 Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung Fused pyrrole compounds, pharmaceutical compositions containing them and their use |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396996A1 Genetically modified fibroblast cell |
| 07/19/2001 | CA2396413A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/19/2001 | CA2396026A1 Phenanthridine-n-oxides |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/19/2001 | CA2393597A1 Indole derivatives as mcp-1 receptor antagonists |
| 07/19/2001 | CA2393592A1 Indole derivatives as mcp-1 receptor antagonists |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115865A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115743A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115716A1 2-phenylpyran-4-one derivatives |
| 07/18/2001 | EP1115712A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 07/18/2001 | EP1115708A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
| 07/18/2001 | EP1115404A1 Use of prostanoid antagonists for the treatment of primary headache disorders |
| 07/18/2001 | EP1115396A1 Pharmaceutically active compounds and methods of use thereof |
| 07/18/2001 | EP1115392A2 Use of n-acylvanillinamide derivatives as agonists of peripheral cannabinoid cb1 receptors |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP1115372A2 Fast dissolving orally consumable films |
| 07/18/2001 | EP0636025B1 Compounds useful for treating allergic or inflammatory diseases |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 07/18/2001 | CN1304401A Calcilytic compounds |
| 07/18/2001 | CN1304321A Composition for transdermal administration of non-steroidal anti-inflammatory drugs |
| 07/18/2001 | CN1304315A Use of cyclosporins in treatment of inflammatory autoimmune diseases |
| 07/18/2001 | CN1304312A Composition and method for treatment and preventing of arthritis and/or autoimmune diseases |
| 07/18/2001 | CN1304311A Bridged indenopyrrolocarbazoles |
| 07/18/2001 | CN1303714A II type collagen oral gastric solubility preparation |
| 07/18/2001 | CN1303701A Chinese medicine for curing rheumatism |
| 07/18/2001 | CN1303685A Production method of leifengshi Zhitong wan for curing rheumatoid disease |
| 07/18/2001 | CN1303684A Dieda fengshi zhitonggao adhesive plaster for curing traumatic injury and rheumatism and its production method |
| 07/18/2001 | CN1068598C Resolution of 1-azabicyclo [2.2.2] octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl) phenyl]methyl] |
| 07/18/2001 | CN1068591C 1,3-dihydro-1-(phenylalkyl)-2H-imdiazol-2-one derivatives having PDEIV and cytokine activity |
| 07/18/2001 | CN1068590C 1,3-dihydro-1-(phonylalkenyl)-2H-imidazol-2-one derivatives having PDEIV and cytokine inhibiting activity |
| 07/17/2001 | US6262127 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/17/2001 | US6262121 Oily patches for external use containing diclofenac sodium |
| 07/17/2001 | US6262119 Methods of treating immunopathologies using polyunsaturated fatty acids |
| 07/17/2001 | US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 07/17/2001 | US6262104 Selective delta opioid agonists and antagonists |
| 07/17/2001 | US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |
| 07/17/2001 | US6262075 Piperidone tachykinin antagonists |
| 07/17/2001 | US6262073 Pharmaceutical methods of use of 5-substituted and 5,5 disubstituted-3,4-dihydroxy-2(5H)-furanones |
| 07/17/2001 | US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation |
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6261606 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/17/2001 | CA2223023C N-hydroxyureas as antiinflammatory agents |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049741A2 A process for isolation of osteopontin from milk |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |